Yamamoto Yukari, Aoyama Yumi, Shu En, Tsunoda Kazuyuki, Amagai Masayuki, Kitajima Yasuo
Department of Dermatology, Gifu University School of Medicine, Yanagido 1-1, Gifu City 501-1194, Japan.
J Dermatol Sci. 2007 Aug;47(2):119-25. doi: 10.1016/j.jdermsci.2007.04.004. Epub 2007 May 29.
Although pemphigus vulgaris (PV)-IgG has been shown to activate urokinase plasminogen activator (uPA) in cultured keratinocytes, activation of uPA is thought to have no primary role in PV-acantholysis, because PV-IgG is still pathogenic in uPA- and tissue-PA-knockout mice.
To determine if PV-IgG-induced uPA activation is due to specific antibody against Dsg3, we examined whether or not pathogenic monoclonal anti-Dsg3 antibody can activate uPA, because PV-IgG is thought to contain antibodies against unknown antigens besides Dsg3.
We stimulated cultured normal human and DJM-1 keratinocytes with monoclonal anti-Dsg3 IgG1 antibodies (pathogenic AK23, AK19 and nonpathogenic AK18, AK20), negative control monoclonal mouse IgG1 and positive control PV-IgG. Cells were treated with IgGs over a time course of 24h, and uPA-protein content and activity in the culture medium were determined by enzyme-linked immunosorbent assay (ELISA) and chromogenic assay, respectively.
The uPA-protein content in samples treated with or without pathogenic, nonpathogenic, control monoclonal mouse IgG1s and PV-IgGs increased continuously up to 24h, with no differences between samples, suggesting a spontaneous secretion. In contrast, uPA activity in the culture medium of cells treated with PV-IgG increased dramatically, whereas that of cells treated with all AK-IgGs and control monoclonal mouse IgG1 did not increase at all.
These results suggest that PV-IgG-dependent uPA activation is not related to anti-Dsg3 antibody activity, which is an essential factor in PV-IgG acantholysis, and that it may be due to other antigens than Dsg3 or unknown factors contained in PV-IgG fraction.
尽管寻常型天疱疮(PV)-IgG已被证明可在培养的角质形成细胞中激活尿激酶型纤溶酶原激活剂(uPA),但uPA的激活被认为在PV棘层松解中不具有主要作用,因为PV-IgG在uPA和组织型PA基因敲除小鼠中仍具有致病性。
为了确定PV-IgG诱导的uPA激活是否归因于抗桥粒芯糖蛋白3(Dsg3)的特异性抗体,我们检测了致病性单克隆抗Dsg3抗体是否能激活uPA,因为PV-IgG被认为除了含有抗Dsg3的抗体外,还含有针对未知抗原的抗体。
我们用单克隆抗Dsg3 IgG1抗体(致病性AK23、AK19和非致病性AK18、AK20)、阴性对照单克隆小鼠IgG1和阳性对照PV-IgG刺激培养的正常人角质形成细胞和DJM-1角质形成细胞。细胞用IgG处理24小时,分别通过酶联免疫吸附测定(ELISA)和显色测定法测定培养基中uPA蛋白含量和活性。
无论是否用致病性、非致病性、对照单克隆小鼠IgG1和PV-IgG处理,样品中的uPA蛋白含量在24小时内持续增加,样品之间无差异,提示为自发分泌。相比之下,用PV-IgG处理的细胞培养基中的uPA活性显著增加,而用所有AK-IgG和对照单克隆小鼠IgG1处理的细胞的uPA活性则完全没有增加。
这些结果表明,PV-IgG依赖性uPA激活与抗Dsg3抗体活性无关,而抗Dsg3抗体活性是PV-IgG棘层松解的一个重要因素,并且可能归因于除Dsg3之外的其他抗原或PV-IgG组分中含有的未知因素。